Fundz

SERB Pharmaceuticals Appoints Dr. Vignesh Rajah as Chief Medical Officer

PRIVATENov 17, 2025

Company

SERB Pharmaceuticals

ParisManufacturingBiotechnologyHealth Care

Description

SERB Pharmaceuticals has announced the appointment of Dr Vignesh Rajah as its new Chief Medical Officer. Dr Rajah's extensive experience in the medical field is expected to advance SERB’s scientific and medical capabilities.

Who to call at SERB Pharmaceuticals, and when

A new leader at SERB Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day SERB Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SERB Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SERB Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SERB Pharmaceuticals

Location

40 Avenue George V

Paris, Ile-de-France, France

About

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. SERB operates in the US as BTG Pharmaceuticals. Learn more at https://SERB.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SERB Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Vignesh
Likely contact at this company
••••••••@••••••••

See Vignesh's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for SERB Pharmaceuticals's next move

Learn about Strategic plan

SERB Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.